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Abstract
Aims: In this study we investigated the relationship between cardiovascular instability and the size of the developed
ischaemic lesions during carotid stent implantation by diffusion-weighted (DWI) magnetic resonance (MR) examination.
Material and methods: We retrospectively analyzed anaesthesia reports and follow-up MR examinations after stent implan-
tation of 192 patients in a 3-year period. Nineteen aspects of cardiovascular status were analyzed. We registered the
duration of the intervention, low and high blood pressure (BP) values during anaesthesia and heart rates. The fluctuations
of BP and heart rate and the time of their compensations after the stent expansion were also recorded. Values were
compared with the number and the size of ischaemic lesions on DWI scans. We used Spearman and Kendall rank
correlations and Welch’s tests for statistical analysis. Values of p  0.05 were considered as statistically significant.
Results: Decreased heart rate significantly correlated with the number (p¼ 0.0123) and size (p¼ 0.00323) of ischaemic
lesions during stent expansion. Other cardiovascular parameters did not show any significant correlations.
Conclusions: Our results indicate that only heart rate attenuation affects the size of ischaemic lesions; thus the prevention of
bradycardia is highly important.
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Introduction
Atherosclerosis leads to increased mortality and
morbidity in the Western world. Morphologically, the
atheromatous intimal plaque is pathological. It is a
well-circumscribed lesion that bulges into the lumen,
the cut surface of which is yellowish-white.
Symptoms are the result of complications caused by
the plaque. The structure of the plaques is important
in the evolution of symptoms. Instable, vulnerable pla-
ques have a greater lipid core than the covering fibrous
cap. In these cases, haemodynamic changes can lead to
the rupture of these plaques easily. The stable plaque
grows slowly for several years, gradually bulging into
the lumen and progressively decreasing the amount of
circulating blood in the stenotic lumen.1
Atherosclerosis can damage cervical blood vessels
too. The symptoms of carotid stenosis are broad, and
it can also be asymptomatic. It is considered as symp-
tomatic when transitory ischaemic attack (TIA), amau-
rosis fugax or ischaemic stroke has occurred on the
ipsilateral side of the stenosis in the last 6 months
and neurological symptoms originate from carotid
stenosis.2
There are several ways to treat carotid stenosis
besides medications. Carotid angioplasty, the minimal-
ly invasive, interventional procedure, competes with
carotid endarterectomy as the oldest method. Each
method has its advantages and disadvantages. During
percutaneous transluminal angioplasty, a fluoroscopy-
guided catheter is inserted into the carotid artery. On
reaching the stenosis, a balloon is inflated and a stent is
deployed to achieve the correct size of the lumen.3–5
Microembolization and hypoperfusion during the
procedure are well-known adverse events accompanying
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carotid stent implantation that may cause ischaemic
injury of the brain. Microembolization means that
small parts of the plaque are detached and may occlude
vessels distally. Any mechanical trigger on the plaques
such as contact by a catheter, balloon dilatation or stent
implantation can detach particles from them. Ischaemic
lesions developing this way are rarely clinically symp-
tomatic, but they are traceable by magnetic resonance
(MR) examination. It must be stressed that late embo-
lization is also an important complication and may lead
to ischaemic injuries as well.6,7
Bradycardia and hypotonia often occur during bal-
loon catheter dilatation and stent implantation. They
may result in brain hypoperfusion through the baror-
eceptors of the carotid system and its reflexes. At the
bifurcation of the common carotid artery, carotid sinus
and glomus caroticum can be found. Both areas are
rich in baroreceptors. These receptors are sensitive to
mechanical triggers such as the tension of the blood
vessel’s wall. Mechanoreceptors affect the heart chro-
notropically and dromotropically via the fibres of the
vagus nerve and the thalamus. In the event of hyper-
tension baroreceptor reflex decreases blood pressure
(BP) by mitigating heart rate and total peripheral resis-
tance.8–10
To sum up, invasive treatment of carotid stenosis
can provoke cerebrovascular complications. However,
therapy is essential since atheromatous plaques and
stenosis are potentially harmful. The risks and benefits
of the intervention should always be considered.
The aim of our retrospective study was to find cor-
relation between the developed cardiovascular instabil-
ity and the size and number of ischaemic lesions, both
during the whole interventional procedure and imme-
diately after carotid stent implantation using diffusion-
weighted (DWI) MR examination.11,12
Methods and materials
Patients and intervention protocol
The medical records of 192 patients were examined
retrospectively in the Department of Radiology at the
University of Szeged. The patients received carotid
stents between 30 June 2014 and 17 July 2017. We ana-
lyzed plaques with the help of the previously obtained
carotid computed tomography (CT) angiogram. We
did not perform an intervention if the density of the
plaque was less than 60 Hounsfield units (HU) or we
found ulcerated plaque or concentric calcified plaque.
The degree of the stenosis was between 75% and 90%.
Interventions were performed under local anaesthesia
with anaesthesiologist supervision. During the proce-
dure the common femoral artery was punctured, the
catheter was guided to the carotid stenosis, the balloon
dilatation was performed and the stent was implanted
thereafter. Wallstent (Boston Scientific, Marlborough,
MA, USA) was implanted in every case. A embolic
protection device was not used. All of the interventions
were performed by an expert radiologist. The operator
had special licence for neuroradiology interventions.
After the interventions, the patients were observed
closely for 48 hours. The procedure is depicted in
Figure 1 showing the status before and after balloon
dilatation with the implanted stent. An MR scan was
performed 24 hours after the procedure. Circulatory
parameters during the interventions were collected
first. Systolic and diastolic BP values, heart rate, respi-
ratory rate and oxygen saturation in every minute were
collected from the medical records of anaesthesiolo-
gists. The developed ischaemic areas were detected
using DWI MR scans.
Examined cardiovascular parameters
For every intervention two different statuses were
investigated according to the reports. Firstly, cardio-
vascular parameters and their changes during the entire
procedure were registered. Additionally, changes of
cardiovascular parameters at the moment of the stent
dilatation were recorded for all patients. The start and
the end point were recorded to measure the whole
duration of the procedures. We noted every case
where hypotension occurred; furthermore, we recorded
the minimum value and the duration of the periods of
hypotension. Hypotension was defined as systolic BP
lower than 100mmHg or diastolic BP lower than
60mmHg. We noted every case where hypertension
occurred and recorded its duration and the highest
BP value. In the case of hypertension, we divided the
values into two subgroups depending on whether
the systolic BP was over 140mmHg or 160mmHg.
The duration and the lowest heart rate of bradycardia
were also recorded. The durations of tachycardia
with the highest heart rate were noted too.
Bradycardia was determined as less than 60 beats per
minute (bpm), tachycardia as more than 100 bpm.
If the BP or heart rate changed, we summarized the
periods with the abnormal values and this was used for
calculations.
We also examined numerous cardiovascular param-
eters at the moment of the stent dilatation. The time
interval between the starting point of the intervention
and the point of the balloon dilatation was registered in
every case. We registered the systolic and diastolic
values of the BP immediately before and after stent
implantation. We recorded the heart rate right before
and after stent implantation also. We used the same
border values given above. The starting point of car-
diovascular instability at dilatation and the point at
which the values returned to normal again, i.e. com-
pensation, were recorded. Compensation time was
determined as the period between them. If the values
were not normalized during the intervention until the
end of the procedure, we used the end point value as
the end of the compensation. Where we noticed hypo-
tension or bradycardia after the dilatation, we recorded
the time that was needed for the registered parameters
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to reset to normal values. Figure 2 shows the cardio-
vascular parameters in an anaesthesiologist’s record.
Determining ischaemic lesions
All of the interventions were scheduled. The patients
had no signs of acute stroke at the time of the proce-
dure; therefore, we did not perform preoperative MR
examinations. Twenty-four hours after the procedure
we performed DWI and fluid-attenuated inversion
recovery (FLAIR) sequences MR examinations. We
used a 1.5 T Signa Excite MRI machine (General
Electric Medical Systems, Fairfield, CT, USA). Areas
with diffusion restriction were identified. The number,
size, the side and the location (supra- or infratentorial)
of these areas were noted. Images were analyzed by two
independent radiologists. Figure 3 demonstrates
ischaemic lesions on a DWI scan.
We compared the two-measurement series with each
other to detect any differences regarding the number of
diffusion-restricted areas. If a difference occurred, the
images were revised. Apparent diffusion coefficient
(ADC) values were measured in all of the questionable
cases. If the ADC value of the lesion was less than
0.007, it was considered as a real diffusion restriction.
Figure 4 shows the ADC value measurement proce-
dure. Extension was determined by the usage of
antero-posterior (AP) and latero-lateral (LL) diame-
ters. In this case the lesions were also measured by
the two independent radiologists. The two
measurements were averaged and then multiplied to
get the areas used for calculations. If a lesion occurred
in more than one slice, then the areas of the same
lesions were added to get its approximate three-
dimensional size. These lesions were considered as
one lesion regardless of the number of slices used to
identify them.
Patients and exclusion criteria
Several patients were excluded because they were not
appropriate for the aim of our study. In total, 37
patients were excluded because of inaccessible or
incomplete anaesthesiologist’s records; 29 patients
were excluded because of motion or metal artefact
during MR examinations and we could not analyse
the images satisfactorily. Additionally, another seven
patients were excluded because we identified cerebral
media artery occlusion or carotid occlusion, or we per-
formed further interventions like subclavian dilatation.
One patient was excluded with statistical outlier values.
Extended ischaemic injuries were found in three cases,
and they were considered as outliers also. In total, 77
patients were excluded because of the above-
mentioned reasons.
Medical records including cardiovascular parame-
ters for the whole procedure and the number size of
ischaemic lesions were complete for 115 patients (55
female, 60 male). The average age was 67.3 years
(range 47 to 87 years). In 45 cases the procedure
Figure 1. Digital subtraction angiography image of a 52-year-old male patient who received stent implantation on the left side.
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was performed on the right side and in 70 cases on the
left side.
Additional patients were excluded because of miss-
ing values at the moment of dilatation. In 29 cases the
exact time of dilatation was not recorded. In 86 cases
the medical records of cardiovascular parameters at the
moment of stent implantation and the number and size
of ischaemic lesions was complete (44 female, 42 of
male). The average age was 66.5 (range 47 to 87
years). Dilatation was performed on the right side in
38 cases and on the left side in 38 cases.
Statistical analysis
Data were analyzed by Microsoft Office ProPlus 365
Excel Analysis ToolPak and IBM SPSS Statistics
Version 25 software. In total, 26 parameters were col-
lected from anaesthesiologists’ records and six param-
eters were collected from MR scans.
Non-parametric statistical tests were used since we
hypothesized that the number and size of ischaemic
lesions are not normally distributed. The following sta-
tistical tests, which do not require normal distribution
of the statistical groups, were used: Spearman rank
Figure 3. Diffusion-weighted magnetic resonance image of a 72-year-old male patient after stent implantation on the left side.
Supratentorial ischaemic lesions are easily identifiable (blue arrows).
Figure 2. Cardiovascular parameters in an anaesthesiologist’s record. Systolic and diastolic BP values (black arrows), heart rate (orange
arrow) and the moment of balloon dilatation (red arrow) were recorded. Parameters are shown in timeline (white arrow) by the record.
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correlation, Kendall rank correlation, Welch test,
Pearson rank correlation. p 0.05 was considered as
statistically significant. Data were presented as mean
standard deviation.
Results
Results of the entire procedure period
Values of the cardiovascular parameters. In total, 115
patients’ cardiovascular parameters were measured
and averaged from the medical records of anaesthesi-
ologists. The average time for the whole procedure was
5519 min (the shortest was 35 min, the longest 140
min). Hypotension was recorded in 26 cases, with the
average time being 1719 min (the shortest lasted for
35 min, the longest 40 min); the lowest value was 75/
35mmHg. Systolic values were over 140mmHg in 100
cases, the average time for which was 4321 min (the
shortest was 3 min, the longest 140 min); the highest
value was 215/115mmHg. Systolic values were over
160mmHg in 59 cases, the average time for which
was 3122 min (the shortest was 5 min, the longest
95 min). Bradycardia occurred in 55 cases, the average
time for which was 1419 min (the shortest was 1 min,
the longest 95 min); the lowest heart rate was 10 bpm.
Tachycardia occurred in six cases, the average time for
which was 3435 min (the shortest was 5 min, the lon-
gest 100 min); the highest value was 140 bpm.
Parameters of ischaemic lesions. Eighty-four out of 115
patients developed ischaemic lesions. In total, 469
lesions were analyzed. The average size was
3.43 3.32mm (APLL). In 26 cases a lesion
appeared in more than one slice because of its exten-
sion. Out of 469 lesions, 262 were on the left side and
207 were on the right side. In total, 462 diffusion
restricted lesions were supratentorial, and seven of
them were infratentorial.
Statistical results for the whole procedure period. All
recorded cardiovascular parameters were correlated
with the number and size of ischaemic lesion. Only
one of the registered cardiovascular parameters did
not correlate significantly. Table 1 summarises the sta-
tistical analysis and p-values. The presence of tachycar-
dia, its period and its maximum values cannot be
interpreted due to the low number of cases.
Results at the moment of stent dilatation
Values of the cardiovascular parameters. Right before dila-
tation the average systolic BP was 15219mmHg, the
diastolic was 7912mmHg and heart rate was 7515
bpm. Right after dilatation the average systolic BP was
13424mmHg, the diastolic was 7215mmHg and
heart rate was 6122 bpm. Out of 86 cases 15 patients
developed hypotension; the shortest compensation
time was 5 min, the longest compensation time was
25 min and the average compensation time was 116
min. Bradycardia occurred in 37 cases; its shortest
compensation time was 2 min, the longest compensa-
tion time was 60 min and the average compensation
time was 810 min. Cardiovascular instability
occurred in 44 cases, and in eight cases both bradycar-
dia and hypotension occurred.
Parameters of ischaemic lesions. Sixty-one out of 86
patients had ischaemic lesions on MR scans after the
procedure. In total, 333 diffusion-restricted lesions in
61 patients were registered. Twenty-six lesions extend-
ed into more than one slice because of their size. In
total, 330 lesions were supratentorial and three lesions
were located infratentorially; 170 lesions were on the
right side and 163 were on the left side. The average
dimension was 3.58 3.49mm (APLL).
Statistical results at the moment of stent dilatation
There was no significant correlation between the dura-
tion of the procedure (starting time of the procedure
and time of the dilatation) and the examined parame-
ters of the ischaemic lesions. We used Kendall rank
correlation for statistical analysis for number of lesions
(p¼ 0.3402) and their size (p¼ 0.4792).
Figure 4. Ischaemic lesion on the left side after stent implantation in a 65-year-old female patient. Diffusion restriction was proved by
apparent diffusion coefficient measurement.
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Statistically, we got more reliable results when the
parameters of the ischaemic lesions were correlated
with systolic and diastolic BP changes during dilatation
compared to the usage of correlation with systolic and
diastolic BP values before and after the dilatation. The
average systolic BP decrease was 18.623.95mmHg
and the diastolic BP decrease was 7.7313.83mmHg
during the dilatation. There was no significant correla-
tion (Kendall rank correlation) between the attenua-
tion of systolic BP and the number of lesions
(p¼ 0.287) and their size (p¼ 0.4661). We also could
not prove a significant difference between the attenua-
tion of diastolic BP and the number (p¼ 0.2832) and
size (p¼ 0.3956) of the lesions. We used the heart rate
decline during the dilatation for the statistical analysis,
the average value for which was 1420.58 bpm. This
alteration correlated significantly with the number of
lesions (p¼ 0.0123) and their size (p¼ 0.00323) by
Kendall rank correlation.
The compensation time of bradycardia did not cor-
relate significantly with the lesion number
(p¼ 0.06472) and size (p¼ 0.2744) by Kendall rank
correlation. The p-value of the number of ischaemic
lesions is approaching the point of p 0.05 and can
indicate a connection between the two variables. The
correlation between the compensation time of hypoten-
sion and ischaemic lesions could not be interpreted due
to the low case number and the outlier values.
Generally, BP decreased after dilatation, but in most
cases it did not decrease below 100mmHg systolic or
60mmHg diastolic value.
Discussion
Correlation between embolization and
cardiovascular instability
Carotid stent implantation is accompanied by micro-
embolization and hypoperfusion, which can lead to
ischaemic brain injury. In serious cases stroke may
develop. Microembolization means that small particles
of the plaques are detached and can reach the brain via
circulation during and after the procedure.13,14
Several studies demonstrated that ischaemic brain
injury after stent implantation cannot be caused by
microembolization exclusively. At the moment of dila-
tation hypotonia and brain hypoperfusion caused by
cardiovascular instability can increase the chances
of MR detectable ischaemic brain lesion develop-
ment.15–17
It is already proven that carotid stent implantation
increases cardiovascular instability, and the barorecep-
tor reflex plays a major role in the evolving hypotonia.
Whether hypo- or hypertension occurs, turbulent
blood flow increases the mechanical effects of cardiac
instability to the injured blood vessel wall. The two
processes potentiate the effect of each other. Several
studies have investigated haemodynamic instability
emphasizing the importance of the postoperative
period. On the contrary just a few studies have
examined the effect of intraprocedural cardiac instabil-
ity.18–20
Our study demonstrates that balloon catheter dila-
tation with stent implantation and the cardiac instabil-
ity during the whole procedure do not significantly
increase the number of MR detectable ischaemic
lesions and extension 24 hours after the procedure.
Only patients with over 160mmHg systolic BP
approached the level of significance. This suggest that
extremely high BP during the procedure can have an
influence on the development of ischaemic lesions.
Regarding this, further investigations are required.
On analysis of our data, we did not find any significant
correlation among the size of periprocedural ischaemic
brain lesions, the amount of time till dilatation, the
duration of the whole intervention and the systolic
and diastolic BP changes during the procedure.
Therefore, the attenuation of systolic and diastolic
BP does not mean there is an additional risk factor
for ischaemic brain lesions, although in extreme cases
Table 1. Correlation of cardiovascular parameters and the number and extension of ischaemic values.
Registered parameters Statistical probe Number of lesions Size of lesions
Duration of the whole procedure Kendall rank correlation p¼ 0.5116 p¼ 0.5369
Presence of hypotension Welch test p¼ 0.7042 p¼ 0.4445
Period of hypotension Kendall rank correlation p¼ 0.9543 p¼ 0.8438
Minimum value of hypotension Kendall rank correlation p¼ 0.8139 p¼ 0.3054
Presence of BP over 140mmHg Welch test p¼ 0.6344 p¼ 0.5093
Period of BP over 140mmHg Kendall rank correlation p¼ 0.2217 p¼ 0.2221
Maximum value of BP over 140mmHg Kendall rank correlation p¼ 0.3846 p¼ 0.4632
Presence of BP over 160mmHg Welch test p¼ 0.0589 p¼ 0.0608
Period of BP over 160mmHg Kendall rank correlation p¼ 0.2399 p¼ 0.3539
Maximum value of BP over 160mmHg Kendall rank correlation p¼ 0.8999 p¼ 0.6734
Presence of bradycardia Welch test p¼ 0.8981 p¼ 0.1147
Period of bradycardia Kendall rank correlation p¼ 0.9872 p¼ 0.5281
Minimum value of bradycardia Kendall rank correlation p¼ 0.2985 p¼ 0.3042
Presence, period and maximum value of tachycardia Not applicable
BP: blood pressure.
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it is necessary to correct them to maintain the integrity
of the circulation. Heart rate attenuation during the
dilatation procedure led to significant correlation
with the ischaemic lesions’ number and size. There
was no significant correlation between the compensa-
tion time of bradycardia and the number of ischaemic
lesions, but the p-value of 0.065 highly suggests a con-
nection between them.
Cardiovascular instability during dilatation can be
explained with the baroreceptor reflex. Activation of it
has negative chronotropic and dromotropic effect via
the parasympathetic nervous system. It is a simple idea
to prevent or treat bradycardia and hypotonia with
atropine.21,22
Atropine is a parasympatholytic drug, and it can be
classified as an anticholinergic agent in other aspects.
At the parasympathetic end plates, it inhibits impulse
conduction competitively by decreasing the parasym-
pathetic tone. Atropine 0.5–1 mg is used to prevent or
treat bradycardia and hypotonia during carotid
stenting.23
Several studies have investigated whether atropine
significantly decreases the incidence of hypotonia and
bradycardia during the procedure. Cayne et al. demon-
strated that receiving atropine as prevention before
dilatation significantly decreases the incidence of hypo-
tonia and bradycardia after dilatation.24 On the other
hand, Qureshi et al. demonstrated that receiving atro-
pine as prevention paradoxically significantly increased
the chance of postoperative bradycardia.25 This
study recommends caution when using atropine. The
Stenting versus Endarterectomy for Treatment of
Carotid Artery Stenosis study7 suggests a protocol of
1 mg of atropine intravenously prophylactically.
According to our study, bradycardia must be com-
pensated and larger heart rate attenuation must be pre-
vented or corrected as soon as possible to avoid the
evolution of ischaemic lesions. We cannot conclude
the same regarding BP parameters, but it is important
to maintain cardiovascular integrity with proper anaes-
thesia during the procedure.
Limitations and additional influencing factors of
embolus formation
For the objectivity we must consider the limitations of
our study. We disregarded patients’ previous clinical
history. Previous symptoms (stroke or TIA), comor-
bidity and risk factors (smoking, body weight, lifestyle)
in particular might be important. We documented the
grade of stenosis and we also performed plaque analy-
sis before the procedure with the help of the previously
obtained CT angiography. Although these aspects are
important and influence the extension of developed
ischaemic lesions, previous studies have already exam-
ined them. Therefore, we did not include these param-
eters in the statistical tests.
Biasi GM et al. investigated whether preprocedural
plaque analysis can provide more precise risk analysis
for periprocedural stroke.26 This study showed that
hypoechogenic, soft plaques are associated with
higher risk for stroke, and therefore they predispose
to stroke. Additional studies indicate correlations
among atherosclerotic plaque structure, plaque rupture
and consecutive ischaemic brain lesions. Plaque
morphology is one of the most important factors
in post-procedural stroke, but this has already
been proven.10,27
The structure of the plaque is not just significant in
embolization, but it also has an important role in the
development of cardiovascular instability. Gupta et al.
demonstrated that calcified plaques predispose individ-
uals to cardiovascular instability.20 Owing to their
stable structures, the force of dilatation mediates
more effectively to the baroreceptors, thus activating
the baroreceptor reflex. Several studies proved that the
incidence of cardiovascular instability is strongly cor-
related with the location of the stenosis. Stent implan-
tation close to the carotid sinus significantly
increased cardiovascular instability compared to more
distant sites.20
Currently, there is no generally accepted guideline
for proper stent selection. We implanted open
Wallstents; therefore, the type of stent has no effect
on our data. Csobay-Novák et al. proposed recommen-
dations for the usage of different stent types.28 They
have also demonstrated that cardiovascular instability
occurs more frequently with implantation of shorter
stents. It can be explained that shorter stents have
stronger radial force to the narrowed blood vessel
wall. Stronger radial force means greater transmural
force stimulating the carotid system’s own receptors,
thus increasing cardiovascular instability. Similarly, a
significant correlation has been proved between circu-
latory fluctuation and the grade of dilatation (differ-
ence in the lumen diameters before and after the
procedure).21,29–31
As outlined above, it is obvious that many studies
have already examined carotid stenting, but several
aspects of this procedure are still unclear. In our
study we aimed to focus on some of those unanswered
questions, and we should consider broadening our
treatise by measuring other parameters.
An additional limitation of our study was that we
did not investigate patients’ medication. According to
other studies, this is an important parameter regarding
the prevention and therapy of bradycardia.
Medications during anaesthesia are included in the
anaesthesiologists’ record. We have been analysing
them, and it will be the subject of our next study.
Tools which can prevent distal embolization are
still an undiscovered area. Several physicians use
these tools, but they cannot give full protection, espe-
cially against prolonged embolization, and their inser-
tion can lead to embolism.32,33 We did not use embolic
protection devises in any of the procedures because
of the additional risk. Thus, we could not investigate
their effect.
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Conclusions
To summarize, we can conclude that cardiovascular
instability and periprocedural embolization caused
ischaemic lesions. They are technically connected to
carotid stent implantations and occur frequently. Our
results suggest that ischaemic lesions and carotid stent
implantations are not independent from each other.
Heart rate attenuation during stent dilatation and
the number and size of ischaemic brain lesions devel-
oped within 24 hours and showed unequivocal corre-
lation. Our study proved clearly that bradycardia
should be prevented or ceased quickly to save brain
tissue. Most of the lesions are asymptomatic but can
still cause the death of millions of neurons, which
cannot be disregarded.
Despite our results, stent implantation can still be
considered safe since intraoperative bradycardia is pre-
ventable or treatable by proper anaesthesia. According
to our results cardiovascular instability and post-
procedural ischaemic lesions can accompany stent
implantation. These effects are a technicality of the
intervention and should be considered at surgical plan-
ning, but they do not mean additional risk.
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